HemoGenix, Inc
Biotechnology ResearchColorado, United States2-10 Employees
HemoGenix, Inc is a biotechnology research contractor based in Colorado Springs, Colorado, offering in vitro toxicity testing services. The company emphasizes detailed, high-quality work and one-on-one consultation to help clients assess toxicity, risk, and safety of drugs or other agents through proprietary in vitro platforms. Its client base includes small to mid-sized biopharmaceutical companies and portions of larger organizations, with services extending to in vitro testing of cells and tissues derived from GLP or non-GLP pre-clinical studies. HemoGenix operates within the contract research landscape and distributes its assays through Science Exchange, reflecting a specialization that complements larger CROs by addressing toxicity testing needs that may not be covered elsewhere. The firm positions itself as a focused provider in the biotechnology research sector, with a stated global reach through partnerships and a continued expansion of its service portfolio. A recent development noted is the availability of its services through Science Exchange, aligning with broader access channels for contract research work.